Results 151 to 160 of about 7,260 (206)
Some of the next articles are maybe not open access.
Dermatologic Therapy, 2022
Alopecia areata (AA) is a recurrent chronic disease that affects hair follicles and results in hair loss. Make an increase in the number, thickness, and length of eyelashes is an important side effect of latanoprost eye drop. This study aimed to evaluate
M. Rafati +5 more
semanticscholar +1 more source
Alopecia areata (AA) is a recurrent chronic disease that affects hair follicles and results in hair loss. Make an increase in the number, thickness, and length of eyelashes is an important side effect of latanoprost eye drop. This study aimed to evaluate
M. Rafati +5 more
semanticscholar +1 more source
Neuroprotective properties of latanoprost
Vestnik oftal'mologii, 2022Glaucoma is the main cause of irreversible blindness in the world. Latanoprost - an ester prodrug of prostaglandin F2α (PGF2α) - was the first prostaglandin analogue used to treat glaucoma. The review shows that latanoprost possesses direct neuroprotective properties such as blocking the entry of calcium ions into neurons and inhibiting the action of ...
openaire +2 more sources
Japanese Journal of Ophthalmology, 2004
Latanoprost is a prostaglandin analogue with well-established efficacy in the treatment of open-angle glaucoma and ocular hypertension. Once-daily administration of this drug for up to 5 years is generally well tolerated both locally and systemically.
Ian Grierson +2 more
openaire +3 more sources
Latanoprost is a prostaglandin analogue with well-established efficacy in the treatment of open-angle glaucoma and ocular hypertension. Once-daily administration of this drug for up to 5 years is generally well tolerated both locally and systemically.
Ian Grierson +2 more
openaire +3 more sources
Latanoprost exposure in pregnancy
American Journal of Ophthalmology, 2004To observe pregnancies exposed to latanoprost, a prostaglandin analog administered in the treatment of glaucoma. Its prescription is limited in pregnancy, because reproduction studies in animals report a high incidence of abortion and human investigations are not adequate.
De Santis, Marco +7 more
openaire +4 more sources
Journal of Ocular Pharmacology and Therapeutics, 2021
Purpose: To investigate the influence of benzalkonium chloride (BAK) on ocular surface disease (OSD) in glaucoma patients receiving ocular-hypotensive agent.
Jo-Hsuan Wu +3 more
semanticscholar +1 more source
Purpose: To investigate the influence of benzalkonium chloride (BAK) on ocular surface disease (OSD) in glaucoma patients receiving ocular-hypotensive agent.
Jo-Hsuan Wu +3 more
semanticscholar +1 more source
Journal of Cataract and Refractive Surgery, 1999
link_to_subscribed_fulltext
Chua, JKH, Lai, JSM, Lam, DSC
openaire +5 more sources
link_to_subscribed_fulltext
Chua, JKH, Lai, JSM, Lam, DSC
openaire +5 more sources
Seminars in Ophthalmology, 1997
Latanoprost is a new topical ocular prostaglandin that decreases intraocular pressure (IOP) by increasing uveoscleral outflow. Its efficacy is comparable with that of timolol and it shows almost complete additivity with timolol. Once daily dosing of 0.005% latanoprost yields a maximal effect with no significant circadian fluctuation in IOP.
Theodore Krupin +4 more
openaire +2 more sources
Latanoprost is a new topical ocular prostaglandin that decreases intraocular pressure (IOP) by increasing uveoscleral outflow. Its efficacy is comparable with that of timolol and it shows almost complete additivity with timolol. Once daily dosing of 0.005% latanoprost yields a maximal effect with no significant circadian fluctuation in IOP.
Theodore Krupin +4 more
openaire +2 more sources
Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma
Drug Development and Industrial Pharmacy, 2020Objective: Glaucoma is a leading cause of irreversible blindness worldwide. Whereas latanoprost is one of the most effective drugs in glaucoma treatment, its eye drops need frequent application leading to lack of patient adherence.
Dina Fathalla, E. Fouad, G. M. Soliman
semanticscholar +1 more source
Latanoprost in hemifacial spasm
Prostaglandins & Other Lipid Mediators, 2002An empirical observation that the prostaglandin derivate latanoprost quited facial spasms in patients with glaucoma prompted us to study latanoprost in non-glaucomatous patients with hemifacial spasms [HFS]. This explorative trial followed an open-label, prospective treatment design.
Luc Crevits +3 more
openaire +3 more sources
The stabilization mechanism of latanoprost
International Journal of Pharmaceutics, 2011The content of latanoprost is likely to decrease in solution because of the adsorption to eye drop containers and hydrolysis. We reduced these problems and established a formulation of latanoprost eye drops which is stable at room temperature. We assume that the additive surfactants form micelles and stabilize latanoprost in this formulation.
Akiko Ochiai, Kazumi Danjo
openaire +3 more sources